Business Development — Consulting

Whether you need to sharpen a launch strategy, develop medical and marketing content, or bridge a capability gap, Evollvere brings senior, hands-on expertise to move your project forward without disrupting internal teams. Our consultants bring 25+ years of commercial biopharmaceutical experience across medical affairs, market access, marketing, sales and organisational transformation — with a particular track record in rare disease, launch excellence and lifecycle management.

Pricing

We work with you in several ways:

Interim FTE / Embedded Support

Medical, commercial, or leadership professionals embedded for 3–12 months.

Project-Based Consulting

Strategic consulting, launches, capability building, medical communications.

Strategic Partnership (Ongoing)

Recurring strategic input on your priorities — customized to your needs and budget.

Team Development

Leadership coaching and capability building programs tailored to your organization.

Every engagement is unique. We scope and price based on your specific situation.

What Our Clients Say

"The Evollvere team brings deep experience in life science marketing and medical excellence, with a strong track record in leading launches and lifecycle management for pharmaceutical and biopharmaceutical products. They are skilled communicators who understand what commercial and field teams need to effectively address customer needs. The team is results-driven and operates with a high level of cultural agility across borders and functional areas."

What we directly deliver

What Our Clients Say

"Evollvere brings rare strategic depth to every engagement — combining critical thinking, creative problem-solving and strong commercial acumen with a genuine understanding of the people behind the business. The team's focus, enthusiasm and drive to make things happen make for both exceptional results and an energising collaboration."

Working with partners to deliver

Market research and market access are delivered with our trusted network of specialist partners, giving you deep functional expertise alongside our core medical and marketing team.

Content & digital development

We support the full content journey — from strategic foundation to tactical deployment across digital and traditional channels.

What we directly deliver

With your in-house or agency partners:

Selected Client Work

Early Access Strategy — Rare Disease

Rare Disease • Market Access & Medical Affairs

Emerging biotech entering Europe

Ahead of the European launch of a life-saving medicine, the company wanted to provide early access for patients while preparing the market with real-world experience, securing a competitive advantage and generating early revenue.

Launch Excellence & Lifecycle Management — Cardio-Renal

 Cardio-Renal / Nephrology • Marketing & Launch

Global pharmaceutical company (Cardio-Renal / Nephrology)

Prepare strategic and tactical plans for a high-potential asset amid rapidly evolving market dynamics, and enable a unified pre-launch campaign with field-team readiness across EUCAN markets.

Medical Communications & Scientific Engagement — Rare Disease

 Rare Disease • Medical Affairs

Global pharmaceutical company (Rare Disease)

Extend rare-disease scientific content beyond its initial audience, ensuring it was medically robust, affiliate-relevant and validated by leading experts.

Reimbursement Dossier & Value Story — Rare Disease

 Rare Disease • Market Access & Medical Affairs

Emerging biotech entering Europe

Ahead of launch, the company needed a Swiss reimbursement dossier that clearly differentiated its therapy from the first-in-class option and supported favourable market access. Timely reimbursement was central to launch: without it, the product faced delayed uptake and weaker competitive positioning.

Want to see more?

More User Cases

Disease Awareness — Rare Disease, Diabetes & Hyperkalemia

 Rare Disease, Diabetes & Hyperkalemia • Marketing & Medical

Multiple global pharmaceutical companies

Low disease awareness and diagnosis rates ahead of major launches across three distinct therapeutic areas, including a rare disease indication.

Digital Transformation — HCP Journey & Omnichannel Content

 Rare Disease • Digital & Omnichannel • FTE for Hire

Global pharmaceutical company transitioning to a digital-first engagement model

The organisation was shifting from a traditional to a digital approach and needed to design an HCP content journey — and the digital tactics to deliver it — that would engage physicians the way they actually think and learn.

Capabilities Assessment & Marketing Academy Design

 Cross-TA • Capability, Marketing & Omnichannel

Global pharmaceutical company (via specialist analytics partner)

Define a capability architecture and close skill gaps for global marketing teams facing evolving digital and omnichannel demands.